Truitt Joseph 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 29, 2020
Insider Transaction Report
Form 4
Truitt Joseph
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-05-28+130,000→ 130,000 totalExercise: $63.72Exp: 2030-05-28→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
- [F2]The stock options vest in four equal installments over the four-year period following the date of grant.